7 Top M&A Highlights of Q3

Mergers & acquisitions took off in the third quarter with some eye-popping and historic buyouts

      View All  


Amgen 185One of the quarter’s largest deals went down in the biotechnology sector. Amgen (AMGN), the largest biotech company by sales, scooped up smaller rival Onyx Pharmaceuticals (ONXX) for $10.4 billion.

Onyx specializes in cancer-fighting drugs, and that’s what piqued Amgen’s interest — especially Kyprolis, a therapy for multiple myeloma.

Article printed from InvestorPlace Media, http://investorplace.com/2013/09/mergers-acquisitions-ma-q3-third-quarter/.

©2016 InvestorPlace Media, LLC

Comments are currently unavailable. Please check back soon.